GO:0031877 somatostatin receptor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031877 somatostatin receptor binding is a molecular function defined as binding to a somatostatin receptor, with the synonym somatostatin receptor ligand.
• The endogenous ligands somatostatin (SST) and cortistatin (CST) bind five G-protein-coupled receptor subtypes (SSTR1-SSTR5) with subtype-selective affinities.
• Binding is mediated by the conserved FWKT motif in SST and distinct transmembrane pockets in each SSTR subtype, as shown by in silico and radioligand studies.
• Somatostatin receptor binding is the molecular basis for somatostatin receptor imaging and peptide receptor radionuclide therapy in neuroendocrine tumors.
• Cortistatin binds somatostatin receptors in wild-type brain but binding is lost in SSTR-deficient mice, confirming receptor specificity.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect ligand-receptor binding and downstream signaling.
Description
Somatostatin receptor binding (GO:0031877) is a molecular function that describes the binding of a ligand to any somatostatin receptor. Somatostatin receptors (SSTRs) are a family of five G-protein-coupled receptors (SSTR1-SSTR5) that mediate the diverse actions of the peptide hormones somatostatin (SST) and cortistatin (CST). This binding event is the first step in a signaling cascade that regulates hormone secretion, cell proliferation, and neurotransmission. Because of its central role in neuroendocrine physiology, somatostatin receptor binding is a major target for diagnostic imaging and therapy in oncology. Understanding the structural and molecular determinants of this binding is therefore of broad biomedical importance.
somatostatin receptor binding At A Glance
| GO ID | GO:0031877 |
|---|---|
| GO term | somatostatin receptor binding |
| Ontology | molecular_function |
| Synonym | somatostatin receptor ligand |
| Definition | Binding to a somatostatin receptor. |
| Major function | Mediates ligand recognition at somatostatin receptors, initiating G-protein-coupled signaling. |
| Ligands | Somatostatin (SST) and cortistatin (CST). |
| Receptor subtypes | SSTR1, SSTR2, SSTR3, SSTR4, SSTR5. |
| Structural motif | FWKT motif in SST is critical for receptor binding. |
| Research relevance | Target for neuroendocrine tumor imaging and therapy. |
What Is GO:0031877?
According to the Gene Ontology, GO:0031877 somatostatin receptor binding is the molecular function of binding to a somatostatin receptor. In other words, it is the activity of a ligand (such as somatostatin or cortistatin) that physically interacts with one of the five somatostatin receptor subtypes (SSTR1-SSTR5). This function is synonymous with being a somatostatin receptor ligand.
Why Is somatostatin receptor binding Important in Cell Biology?
Somatostatin receptor binding is important because it is the molecular trigger for a wide range of physiological effects, including inhibition of hormone secretion, modulation of neurotransmission, and regulation of cell proliferation. Dysregulation of this binding is implicated in neuroendocrine tumors, where receptor overexpression is exploited for diagnosis and therapy. Moreover, understanding the binding mechanism at the atomic level guides the design of subtype-selective drugs and radiopharmaceuticals.
• Controls hormone secretion from pituitary, pancreas, and gastrointestinal tract.
• Mediates antiproliferative and pro-apoptotic effects in neuroendocrine tumors.
• Enables somatostatin receptor imaging with radiolabeled analogs.
• Provides the basis for peptide receptor radionuclide therapy (PRRT).
• Regulates neurotransmission and may influence epilepsy and neurodegeneration.
• Cortistatin binding to SSTRs modulates sleep and immune responses.
• Subtype-selective binding determines distinct physiological outcomes.
• Structural knowledge of binding guides rational drug design.
• Altered binding affinity can lead to endocrine disorders.
• Serves as a model for studying GPCR-ligand interactions.
Molecular Mechanism of somatostatin receptor binding
Ligand recognition and binding pocket
In simple terms: The ligand fits into a specific pocket on the receptor like a key in a lock.
Somatostatin and cortistatin bind to the extracellular loops and transmembrane helices of SSTRs. The conserved FWKT motif in SST is essential for high-affinity binding, as shown by in silico studies. Each receptor subtype has a distinct binding pocket that determines subtype selectivity.
Subtype selectivity and affinity
In simple terms: Different receptor subtypes prefer different ligands, leading to varied effects.
SSTR2 has high affinity for SST-14 and octreotide, while SSTR5 prefers SST-28. SSTR1 and SSTR4 have lower affinity for most synthetic analogs. Radioligand binding studies in wild-type and SSTR-deficient mouse brain confirmed that cortistatin binds specifically to SSTRs.
Conformational changes and G-protein activation
In simple terms: Once the ligand binds, the receptor changes shape and activates signaling proteins inside the cell.
Ligand binding induces conformational changes in the receptor that promote coupling to inhibitory G-proteins (Gi/Go), leading to inhibition of adenylyl cyclase and modulation of ion channels. This is the canonical signaling pathway for all SSTRs.
Regulation by phosphorylation and internalization
In simple terms: After binding, the receptor can be modified and pulled inside the cell to control the signal.
Agonist binding leads to phosphorylation of the receptor by G-protein-coupled receptor kinases (GRKs), followed by arrestin recruitment and internalization. This desensitization process regulates the duration and intensity of somatostatin signaling.
Key Genes Involved in GO:0031877 somatostatin receptor binding
The following genes encode the receptors and ligands that mediate somatostatin receptor binding.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SSTR1 | Somatostatin receptor subtype 1 | Mediates binding with lower affinity for SST-14 |
| SSTR2 | Somatostatin receptor subtype 2 | Primary target for octreotide and PRRT |
| SSTR3 | Somatostatin receptor subtype 3 | Involved in neurotransmission and apoptosis |
| SSTR4 | Somatostatin receptor subtype 4 | Expressed in brain and endocrine tissues |
| SSTR5 | Somatostatin receptor subtype 5 | High affinity for SST-28, regulates insulin secretion |
| SST | Somatostatin preproprotein | Endogenous ligand for all SSTRs |
| CORT | Cortistatin preproprotein | Binds SSTRs in brain, modulates sleep and immunity |
| GNAI1 | Gi protein alpha subunit | Mediates signaling downstream of SSTR binding |
| GNAO1 | Go protein alpha subunit | Couples to SSTRs in neurons |
| ARRB1 | Beta-arrestin 1 | Regulates SSTR internalization after binding |
| ARRB2 | Beta-arrestin 2 | Regulates SSTR desensitization |
| GRK2 | G-protein-coupled receptor kinase 2 | Phosphorylates activated SSTRs |
| GRK3 | G-protein-coupled receptor kinase 3 | Phosphorylates activated SSTRs |
| ADCY1 | Adenylyl cyclase 1 | Inhibited by SSTR signaling |
| KCNJ3 | G-protein-activated inward rectifier K+ channel 3 | Activated by SSTR binding in neurons |
| CACNA1B | Voltage-dependent N-type calcium channel | Inhibited by SSTR binding |
| SSTR2A | SSTR2 splice variant | Used as a diagnostic marker in tumors |
How Is somatostatin receptor binding Regulated?
Somatostatin receptor binding is regulated at multiple levels. Receptor expression levels are modulated by hormones and growth factors. Agonist-induced phosphorylation by GRKs and subsequent arrestin binding lead to desensitization and internalization, reducing the number of available receptors on the cell surface. Additionally, the availability of endogenous ligands somatostatin and cortistatin is controlled by their biosynthesis and secretion.
somatostatin receptor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SSTR2 | Neuroendocrine tumors | SSTR2 knockout cell line for binding assays |
| SSTR5 | Pituitary adenomas | SSTR5 point-mutation knock-in mice |
| SST | Hormone secretion disorders | SST overexpression in pancreatic cells |
| CORT | Sleep and immune disorders | CORT knockout mouse for radioligand binding |
| SSTR3 | Neurodegeneration | SSTR3 knockout neurons for binding studies |
Neuroendocrine tumors
Neuroendocrine tumors frequently overexpress somatostatin receptors, particularly SSTR2, which is exploited for diagnostic imaging and therapy with radiolabeled somatostatin analogs. Binding of these analogs to SSTR2 enables both visualization and targeted radiotherapy.
Pituitary adenomas
Pituitary adenomas often express SSTR2 and SSTR5, and somatostatin analogs are used to treat acromegaly and Cushing's disease by binding to these receptors and inhibiting hormone secretion.
Neurological disorders
Somatostatin receptor binding in the brain modulates neurotransmission, and alterations have been implicated in epilepsy, Alzheimer's disease, and depression. Cortistatin, which also binds SSTRs, has been linked to sleep regulation and neuroprotection.
From somatostatin receptor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SSTR2 mediate octreotide binding? | SSTR2 knockout cell line |
| What is the affinity of a new analog for SSTR5? | SSTR5 point-mutation knock-in |
| Can cortistatin bind all SSTR subtypes? | SSTR1-5 knockout mice |
| Does SSTR2 internalization require GRK2? | GRK2 knockout cells |
| Can we visualize SSTR2 in vivo? | SSTR2-tagged knock-in mouse |
| Does SSTR5 overexpression affect insulin secretion? | SSTR5 overexpression in beta cells |
How to Study the somatostatin receptor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Binding affinity (Kd, Bmax) | Subtype selectivity profiling |
| In silico docking | Predicted binding poses | Ligand design |
| CRISPR knockout screen | Genes affecting binding | Identify novel regulators |
| Flow cytometry | Cell surface receptor levels | Internalization assays |
| Immunohistochemistry | Receptor expression in tissues | Tumor diagnosis |
| PET/SPECT imaging | In vivo receptor binding | Clinical imaging |
| Surface plasmon resonance | Real-time binding kinetics | Ligand-receptor interaction |
Radioligand binding assays
Radioligand binding assays using 125I-labeled somatostatin analogs are the gold standard for measuring somatostatin receptor binding affinity and subtype selectivity. These assays can be performed on membrane preparations from cells or tissues.
In silico molecular docking
Computational docking studies model the interaction between somatostatin analogs and SSTR subtypes, revealing key residues involved in binding. These predictions can guide mutagenesis experiments.
CRISPR-based genetic screens
CRISPR knockout libraries can identify genes required for somatostatin receptor binding and signaling. Such screens have revealed modifiers of GPCR function.
Imaging and flow cytometry
Fluorescently labeled somatostatin analogs can be used to visualize receptor binding by microscopy or flow cytometry. This allows assessment of receptor internalization and trafficking.
How CRISPR Can Be Used to Study GO:0031877 somatostatin receptor binding
Knockout
CRISPR knockout of SSTR subtypes in cell lines allows researchers to determine which receptor mediates specific binding and signaling events. For example, SSTR2 knockout cells show loss of octreotide binding.
Point Mutation
Introducing point mutations in the binding pocket of SSTRs can reveal critical residues for ligand interaction. This approach validates in silico predictions.
Knock-in
Knock-in of tagged SSTRs (e.g., GFP or HA) enables visualization and purification of receptor complexes for binding studies. Knock-in of disease-associated mutations can model altered binding.
Overexpression
Overexpression of SSTRs in heterologous cells increases receptor density for binding assays and allows study of signaling in a controlled background.
How EDITGENE Supports somatostatin receptor binding Research
Researchers studying somatostatin receptor binding-related genes often need to determine whether a candidate gene is causally involved in ligand recognition, receptor trafficking, or downstream signaling. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for somatostatin receptor binding research.
Frequently Asked Questions About somatostatin receptor binding
What is GO:0031877 somatostatin receptor binding?
GO:0031877 is a Gene Ontology molecular function term defined as binding to a somatostatin receptor. It is synonymous with being a somatostatin receptor ligand.
What genes are involved in somatostatin receptor binding?
The main genes are SSTR1, SSTR2, SSTR3, SSTR4, SSTR5, SST, and CORT, which encode the receptors and their endogenous ligands.
How does somatostatin bind to its receptor?
Somatostatin binds via its conserved FWKT motif to the transmembrane pocket of SSTRs, inducing conformational changes that activate G-proteins.
What is the role of cortistatin in somatostatin receptor binding?
Cortistatin is an endogenous ligand that binds somatostatin receptors in the brain, as shown by radioligand binding in wild-type but not SSTR-deficient mice.
Which somatostatin receptor subtype is most important for imaging?
SSTR2 is the most important subtype for somatostatin receptor imaging and therapy because it is highly expressed in neuroendocrine tumors.
How can I study somatostatin receptor binding in the lab?
Common methods include radioligand binding assays, in silico docking, CRISPR knockout screens, and imaging with fluorescent analogs.
What diseases are associated with somatostatin receptor binding?
Neuroendocrine tumors, pituitary adenomas, and neurological disorders such as epilepsy and Alzheimer's disease.
Can CRISPR be used to study somatostatin receptor binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect receptor-ligand interactions.
What are the therapeutic applications of somatostatin receptor binding?
Somatostatin analogs are used for peptide receptor radionuclide therapy and to inhibit hormone secretion in tumors.
What is the difference between somatostatin and cortistatin binding?
Both bind SSTRs, but cortistatin has additional roles in sleep and immunity, and its binding is subtype-dependent.
Conclusion
Somatostatin receptor binding (GO:0031877) is a fundamental molecular function that underlies the diverse physiological actions of somatostatin and cortistatin. Its importance spans endocrinology, neurobiology, and oncology, where it serves as a target for imaging and therapy. Continued research using CRISPR models and advanced binding assays will further elucidate the structural and functional determinants of this interaction.
References
- 1. Börzsei R et al.. 2022. Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4.. Int J Mol Sci 23(13) PMID: 35805885
- 2. Zhang B et al.. 2025. Structure and Function of Somatostatin and Its Receptors in Endocrinology.. Endocr Rev 46(1):26-42 PMID: 39116368
- 3. Mikołajczak R et al.. 2016. Radiopharmaceuticals for somatostatin receptor imaging.. Nucl Med Rev Cent East Eur 19(2):126-32 PMID: 27479790
- 4. Oberg K. 2004. Future aspects of somatostatin-receptor-mediated therapy.. Neuroendocrinology 80 Suppl 1:57-61 PMID: 15477719
- 5. Pérez DJ et al.. 2023. In silico Study on the Binding Interactions of SSTA and (18)F-SSTA Towards Somatostatin Receptor Subtype 2.. Anticancer Agents Med Chem 23(9):1048-1066 PMID: 36600623
- 6. Bruns C et al.. 1995. Characterization of somatostatin receptor subtypes.. Ciba Found Symp 190:89-101; discussion 101-10 PMID: 7587655
- 7. Barnett P. 2003. Somatostatin and somatostatin receptor physiology.. Endocrine 20(3):255-64 PMID: 12721505
- 8. Spier AD et al.. 2005. Cortistatin radioligand binding in wild-type and somatostatin receptor-deficient mouse brain.. Regul Pept 124(1-3):179-86 PMID: 15544857
